Expression miniarrays and uses thereof

Abstract

The present invention provides methods and devices for making new and inexpensive miniarrays suitable for gene expression analysis. Also provided herein are methods of diagnosis for specific tissue or condition using specialized diagnostic miniarrays that exhibit specific visual pattern as diagnostic readout.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This non-provisional patent application claims benefit of provisional patent application U.S. Ser. No. 60 / 248,247, filed Nov. 14, 2000, now abandoned.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] The present invention relates generally to the field of gene expression array technology. More specifically, the present invention relates to the making and uses of larger format miniarrays that have similar analytic and diagnostic values as expression microarrays. [0004] 2. Description of the Related Art [0005] Prior to the development of high density expression microarrays, low density nucleic acid hybridization arrays were commonly manufactured by hand or with limited automation. These low density nucleic acid hybridization arrays were used to detect concentration or sequence differences between samples or to simultaneously detect and compare complex analyte samples containing unknown products or a mix of multiple produc...

AI Technical Summary

Benefits of technology

This approach results in economic, high-quality expression assays with diagnostic value comparable to high-density microarrays, facilitating customizable miniarrays for disease-specific diagnostics and reducing costs and complexity in manufacturing and scanning without compromising sensitivity or quantification.

Problems solved by technology

Such macroarray formats are unsuitable for repetitive applications or high throughput, high-density analyses.

However, this approach remains largely a manual procedure with variation in spot size and volume, and limitations on reproducible manufacture.

These methods involved complex methods and equipment, and the probes generated were short, i.e., 20 to 25 bases.

The need to miniaturize these expression arrays is due to the fact that mRNA samples available for such analyses are frequently quite limited and methods to amplify the sample products are inefficient.

Moreover, hybridization kinetics is very slow in large volumes of hybridization solution.

However, the development of these miniaturized, high density arrays comes at great cost and limitations, since the equipment required is complex and delicate, the pin heads or jets must be thoroughly washed and cleaned between sample loadings, specialized temperature and humidity controls and enclosures are required, and complex robotic procedures must be programmed for each run.

Such miniaturization also requires the use of very expensive, specialized labeling reagents.

Moreover, while these expression microarrays allow a high throughput overview and assessment of the relative frequency of different gene transcripts in a sample, these methods are limited by significant deficiencies in quantification and sensitivity (8, 12-13).

However, effective multi-analyte amplification typically requires the provision of at least one unique primer for each type of gene product amplified, and commonly available PCR procedures such as RT-PCR and multiplex PCR have only been used successfully to amplify a limited number of the gene products in a sample (U.S. Pat. No. 5,807,680).

Inconsistency of these methods renders them useful only for identifying unusual or novel gene expression products, and they have not been devised or employed for use with expression microarrays or DNA chip analyses (14-16; U.S. Pat. Nos. 5,104,792, 5,262,311, 5,580,726, 5,665,547, 5,789,206, and 5,882,856).

The prime difficulty with many of these amplification methods stems from the use of short arbitrary or random primers that can give variable results from gene to gene under different temperature and hybridization conditions such that they are unsuitable for repeated diagnostic analyses.

Therefore, some products may not amplify well, and rare or down-regulated transcripts may be under-represented (11).

Additionally, mammalian mRNA samples include very large gene transcripts 6 to 12 thousand nucleotides long that cannot be amplified reliably by routine PCR methods.

Consequently, global PCR amplification of a pool of mRNA-derived cDNA probes has not been attempted or successfully accomplished with DNA chip or expression microarray analyses.

Based on the above reasons, currently available exponential amplification methods cannot be validly applied to multi-analyte gene expression analysis.

However, such amplification is incremental and finite, with a typical duplication of 20-60 copies, and the amplified products it produces are antisense RNAs which are degradable (17; U.S. Pat. Nos. 5,972,607 and 5,716,785).

However, this amplification method is also limited in the number of copies typically made from a sample (only 68 fold duplication demonstrated).

Thus, prior art regarding gene expression arrays is deficient in methods and instruments to amplify a test sample effectively, to create and analyze arrays easily and reliably, and to provide less costly arrays that possess equivalent or improved analytic and diagnostic value.

Images